Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms.


Pergolini I., Jäger C., Safak O., Göß R., Novotny A., Ceyhan G. , ...More

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol.19, pp.171-179, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19
  • Publication Date: 2021
  • Doi Number: 10.1016/j.cgh.2020.04.090
  • Title of Journal : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Page Numbers: pp.171-179
  • Keywords: Metabolic Disorders, IPMN, Malignant Progression, RISK-FACTORS, PANCREAS, PROGRESSION, GUIDELINES, MANAGEMENT, PREDICTORS, DIAGNOSIS, MELLITUS, DUCT, IPMN

Abstract

BACKGROUND & AIMS: The role of diabetes in intraductal papillary mucinous neoplasms (IPMNs) is not known. We investigated the prevalence of diabetes among patients with resected IPMNs and the association between diabetes, clinical and morphological features, and high-grade dysplasia or invasive cancer.